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ABSTRACT 
 
Background: In patients with severe forms of Parkinson’s disease (PD), deep brain 
stimulation (DBS) commonly targets the subthalamic nucleus (STN). Recently the 
mean 3-D Morel-Atlas of the basal ganglia and the thalamus was introduced. It 
combines information contained in histological data from ten post-mortem brains. We 
were interested whether the Morel-Atlas is applicable for the visualization of 
stimulation sites. 
 
Methods: In a consecutive PD patient series we documented preoperative MRI 
planning, intraoperative target adjustment based on electrophysiological and 
neurological testing, and perioperative CT target reconstruction. The localization of 
the DBS electrodes and the optimal stimulation sites were projected onto the Morel-
Atlas. 
 
Results: We included 20 patients (median age 62y). The active contact had mean 
coordinates Xlat=±12.1mm, Yap=-1.8mm, Zvert=-3.2mm. There was a significant 
difference between the initially planned site and the coordinates of the postoperative 
active contact site (median 2.2mm). The stimulation site was - on average - more 
anterior and more dorsal. The electrode contact used for optimal stimulation was 
found within the STN of the atlas in 38/40 (95%) of implantations. 
 
Conclusions: The cluster of stimulation sites in individual patients - as deduced from 
preoperative MR, intraoperative electrophysiology and neurological testing – showed 
a high degree of congruence with the atlas. The mean 3D Morel Atlas is thus a useful 
tool for postoperative target visualization. This represents the first clinical evaluation 
of the recently created atlas. 
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INTRODUCTION 
 
Deep brain stimulation (DBS) has become a widespread therapy for several 
neurological indications [4]. DBS has become a standard treatment for patients with 
advanced Parkinson’s disease (PD). For many patients a site within the subthalamic 
nucleus (STN) is chosen as an efficient target site to improve motor symptoms [3, 5, 
6, 22].  
In surgical practice the anatomical location of the STN in individual PD 
patients is identified by several complementary approaches. (1) Preoperatively, MR 
images are scanned for a hypointense zone, which is caused by a susceptibility 
artefact due to iron enrichment in the subthalamic area [21]. This zone is used to 
identify the STN (“direct targeting” [2]). However, this zone does not necessarily 
correspond to the anatomical boundaries of the STN [12, 19]. (2) Intraoperatively, the 
location of the STN is verified by stepwise electrophysiological recording of neuronal 
activity with micro-electrodes. This measurement features the highest specificity and 
provides a spatial resolution in the submillimeter-scale along the electrode trajectory. 
Furthermore, electrophysiological recording shows a good correlation with the 
localization of STN in MR [16]. (3) Intraoperative neurological testing in the awake 
patient documents undesired side effects and clinical efficacy of the stimulation.  
For postoperative documentation, stimulation sites in individuals can be 
projected on an atlas. There are a number of two-dimensional atlases that use the 
intercommissural line as a reference [11, 13, 17]. Since these atlases are based on 
brain slices, the spatial resolution is highly anisotropic: Very high within the slices and 
in the range of a millimeter in the direction perpendicular to the slices. Furthermore, 
due to the relatively small number of brains used for these atlases, a bias towards an 
individual brain might occur. To overcome these problems, the Yelnik group has 
constructed a three-dimensional atlas from one brain [23], which can be deformed to 
adapt to each individual patient [1]. In a different approach, a high-resolution, three-
dimensional model of thalamic and subthalamic structures (3D-Morel Atlas) was 
recently constructed by combining information contained in histological data from ten 
post-mortem brains [10].  
In the current study, we projected the implanted electrodes of a group of PD 
patients onto the 3D-Morel Atlas. We chose PD patients because the individual 
patient’s STN can be localized on the basis of radiological, electrophysiological and 
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neurological information. We use this information with the dual aim to visualize the 
optimal stimulation sites and to validate the applicability of the atlas for this purpose.  
 
 
METHODS  
 
Patient inclusion criteria  
We included all consecutive patients implanted with DBS electrodes in the 
STN for the treatment of PD in 2010 and 2011. Collection of personal data and 
scientific workup was approved by the institutional ethics review board (Kantonale 
Ethikkommission E-50/2009) and all patients gave their written informed consent. All 
surgeries were performed by the last author (OS). 
 
Preoperative imaging and target planning  
We followed a standard procedure known as “image based direct targeting“ 
[2]. Preoperative MR images were obtained on a Philips Achieva 3T Scanner with the 
following two protocols: T1W_3D_TFE (FOV AP 240mm RL 240mm FH 160mm, 
Voxel size 1mm x 1mm x 1 mm, Slice orientation transverse, Scan mode 3D, TE 
6ms, TR 10ms, Flip angle 8°, Scan duration 4:51 min) and T2W_3D_VISTA (FOV AP 
240mm RL 240mm FH 160mm, Voxel size 1mm x 1mm x 1 mm, Slice orientation 
transverse, Scan mode 3D, TE 270ms, TR 2500ms, Flip angle 90°, Scan duration 
7:42 min). The scans were fused using the StealthMerge algorithm on the Medtronic 
Framelink Stealth Station (www.medtronic.com). Then ventricular borders of the 
anterior and posterior commissures (AC, PC) were determined to obtain the mid-
commissural point (MCP). Target planning was initiated at Xlat=±12mm, Yap=-4mm, 
Zvert=-4mm with respect to MCP and then adapted to the hypointense zones 
associated with the nucleus ruber (RN), the substantia nigra (SN) and the STN in the 
MR images of the individual patient.  
 
Intraoperative procedures 
Electrode penetration to target was guided by a stereotactic frame (Riechert-
Mundinger, www.inomed.de). We used up to 5 electrodes with a distance of 2 mm 
between electrodes (central, anterior, posterior, medial, lateral trajectory). By micro-
electrode recording (MER), we performed electrophysiological recordings. An 
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increase of MER background activity indicates the dorsal border of STN with 
submillimeter accuracy. Thereafter, during test stimulation through a macroelectrode, 
we performed a neurological testing of the cardinal symptoms of PD and documented 
side effects. On this basis we determined the optimal site for stimulation. Then, the 
neurosurgeon implanted the definitive stimulation electrode (Medtronic Model 3389). 
 
CT-based target reconstruction 
After bilateral electrode implantation, we obtained a perioperative CT image to 
eliminate geometric image distortion (Siemens Sensation 64, Spiral CT without 
gantry tilt, axial scan reconstructed to slice thickness 1mm). The CT image was fused 
with the preoperative MRI scans using the StealthMerge algorithm on the Medtronic 
Framelink Stealth Station. We then reconstructed the localization of the lowest 
contact of the stimulation electrode in AC-PC coordinates and the angle from the 
mid-sagittal plane (AMSP) and the angle from the axial plane (AFAP). 
 
Clinical optimization of the stimulation site 
After implantation, stimulation was started at the optimal contact determined 
during intraoperative neurological testing. In some patients the stimulation was 
adapted to optimize clinical impact and to reduce side effects. The stimulation was 
optimized over a follow-up of at least 3 months. We documented the contact that was 
finally selected for stimulation. 
 
The mean three-dimensional Morel Atlas 
We present here a 3D version of the stereotactic Morel Atlas. A detailed 
description of the atlas can be found in [10, 13]. In brief, this atlas was constructed in 
the following way. 1) The structures of interest were analyzed in three planes 
orthogonal to each other and oriented parallel or perpendicular to the reference 
stereotactic plane passing through the centers of AC and PC. 2) The delineation of 
structures based on multiarchitectonic criteria provides a high histological resolution. 
3) The slices were provided at small and regular intervals. Furthermore, the atlas is 
based on histological data taken from 10 postmortem brains, which reduces the bias 
towards a single brain. This results in a high-resolution, three-dimensional model of 
the anatomical structures of interest.               
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The STN of the 3D Morel Atlas compared with a recent MR study 
In a recent study, the anatomy of the STN in 8 post mortem tissue blocks was 
documented by high resolution MR with histological validation [12]. For the maximal 
distance in the axial plane from medial to lateral tip these authors obtained a mean of 
x=12mm, compared to 8.9mm in the mean atlas used here. The maximal distance in 
axial plane between the anterior and posterior borders perpendicular to the width 
measurement was in average y=3.2mm (3D Morel Atlas 5.5mm). The maximal height 
obtained from the slices was in average z=6.6mm (3D Morel Atlas 5.7mm). The STN 
is oriented at approximately 40° to the midline (3D Morel Atlas 38°). This indicates 
that the mean STN volume used here has a more rounded shape, probably due to 
the fact of averaging over individual brains. 
                                                                                                                           
Projection of stimulation electrodes onto the 3D Morel Atlas 
The stimulation electrode was projected onto to the atlas based on the 
localization of its lowest contact and of the angles AMSP and AFAP. The atlas and 
the electrode are represented by digital objects in .vtk format that are handled by the 
Parallel Visualization Application ParaView (www.paraview.org). The atlas is 
constructed such that all structures of the right hemisphere have been mirrored along 
the midsagittal plane. Consequently, in our application of the atlas, electrodes 
implanted in the right subthalamic region have been mirrored along the midsagittal 
plane to represent an electrode in the left subthalamic region. Since the locations of 
left and right STN are correlated in most patients, the left and right stimulation sites in 
the same patient are not statistically independent. 
 
Inter-individual variability in lateral direction. 
For the projection of coordinates of individual patients onto a mean atlas, the 
inter-individual variability poses a major challenge. In our study, the atlas was not 
distorted so that the AC-PC distance remained fixed to 26 mm. For the lateral 
direction, there is strong correlation between ventricular width and the laterality of the 
hypointense zone reflecting the STN in MR images [8]. Therefore, to account for the 
variability in ventricular width of the patients’ brain, the atlas was shifted in lateral 
direction for an alignment with the individual brain at the thalamo-ventricular border.  
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RESULTS  
 
Patient population 
We included 20 patients with L-dopa responsive idiopathic PD (8 female, 
median age 62 years, range 42-76 years). All patients were implanted bilaterally, 
resulting in a total of 40 electrode implantations. Median AC-PC length was 25mm 
(range 22.6-27.6mm). The median width of the third ventricle was 4.3mm (range 2.0 
– 9.0mm). Median duration of disease was 11.5 years (range 1-19 years). Akinesia 
and rigidity were present in all patients. Tremor was present in 17 patients, 6 of them 
had a tremor-dominant form of PD. The median score of Unified Parkinson's Disease 
Rating Scale (UPDRS part III) was 52 preoperatively (medication OFF) and improved 
to 15 postoperatively (medication ON, stimulation ON).  
 
Intraoperative procedures 
We tested all 5 electrode trajectories for 6 of the 40 electrode implantations   
(15%). Four trajectories were tested in 5 (13%), and 3 in 11 (28%) implantations. In 
about half of the implantations, the number of trajectories tested was restricted to one 
(9 cases, 28%) and two trajectories (9 cases, 28%). Most frequently tested were 
central (all implantations, 100%) and medial (28/40 implantations, 70%) trajectories. 
Lateral (18/40, 45%), anterior (14/40, 35%), and posterior (9/40 23%) trajectories 
were less frequently chosen. The use of trajectories was identical in left and right 
hemispheres in 12/20 patients (60%), differed by one trajectory in 6/20 patients, and 
by three trajectories in 2/20 patients.  
The anterior trajectory was tested in 14 cases. The micro-electrode recording 
indicated only a short passage through STN (median 1.0mm, range 0.0-6.5mm). 
Neurological testing ensued in only 3 cases and gave optimal results in one patient 
only. 
The final stimulation electrode (Medtronic Model 3389) was implanted through 
the central trajectory in 24/40 implantations (60%), through the medial trajectory in 
11/40 implantations (28%), lateral and posterior two each (5%) and anterior in one 
implantation (3%). 
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Postoperative reconstruction of stimulation sites 
The average coordinates of all 40 active stimulation sites were 
Xlat=12.1±1.3mm (lateral), Yap=-1.8±1.4mm (posterior of MCP), Zvert=-3.2±1.3mm 
(ventral of MCP) with AFAP=56° and AMSP=26°. The median Euclidian distance 
(bias) to the preoperatively determined target site was Δ=2.2mm with the median 
deviations Δ Xlat =0.2mm, Δ Yap =1.4mm, Δ Zvert =0.7mm. Thus, the optimal 
stimulation site, which was determined in postoperative neurological testing, was 
more dorsal than planned preoperatively. Constrained by the angle of the electrode 
trajectory, the optimal site was also more anterior than planned preoperatively.  
 
Projection of electrodes and optimal stimulation sites onto the atlas 
Figure 1A shows the atlas and a reconstructed electrode as viewed from 
anterior. In this penetration, the electrode enters the STN from antero-lateral at its 
dorso-lateral border in the plane of the STN and exits ventrally.  
We finally computed coordinates of the optimal stimulation site as assessed by 
postoperative clinical testing. The sites are represented in Figure 2 for all 40 
penetrations. While the stimulating pole of the electrode has diameter 1.27mm and 
length 1.5mm, we chose spheres of diameter 0.4mm for better visibility. Of the 40 
penetrations, 38 (95%) showed the pole of optimal stimulation within or in direct 
contact with the atlas’ STN (95% confidence interval [83.1-99.4%]). All stimulating 
poles (100%) were within 2mm from STN, so that stimulation would modulate STN 
activity at this distance [7]. The red cylinder in Figure 2 depicts the mean coordinates 
of the optimal stimulation sites in the dorso-lateral STN.  
 
 
DISCUSSION  
 
Inter-individual variability and the mean atlas 
This study describes the mapping of anatomical information of a group of 20 
individual patient brains onto an atlas derived from a group of 10 brains. The 
variability in the 40 brain hemispheres is accounted for at three levels. First, in the 
most important step (“direct targeting” [2]) we set the target into the hypointense zone 
in MR, which roughly corresponds to the STN [12]. This target coordinate was then 
adjusted on the basis of, second, micro-electrode recording and, third, neurological 
testing. We finally reconstructed the coordinate of the sites of optimal stimulation 
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based on postoperative follow-up examinations at least 3 months after surgery. 
Therefore, the individual stimulation sites contain anatomical information on the 
individual patient’s brain hemisphere.  Over all patients we obtain a distribution of 
optimal stimulation sites (Figure 2). The distribution is a cluster that is narrow 
compared to the extent of the STN. 
The improvement in UPDRS was not related to the optimal stimulation site 
being situated within or outside the atlas’ STN. We therefore assume that the 
deviation from the atlas’ STN is not due to suboptimal surgical procedures but 
reflects the individual variability of the patients, be it in anatomy, age, disease 
duration or preoperative response to levodopa [9]. 
 
Adaptation of the mean atlas to landmarks 
Apart from MCP, which is used to align the atlas with the patient's brain, there 
are a number of landmarks, which are known to correlate with selected features of 
the STN [8]. On this basis the Yelnik Atlas [23] is deformed to adapt to each 
individual patient brain [1]. However, the correlation with most landmarks is rather low 
[8] and each deformation of the atlas introduces a new variable that must be justified. 
We have therefore restricted ourselves to the parameter "ventricular width", which is 
readily available and shows the highest correlation (0.73) with STN laterality [8]. We 
adjusted for the ventricular width of the patients to normalize the laterality of the STN. 
 
Limitations in targeting, electrode placement and reconstruction 
There are several sources of error that may affect the accuracy of the 
electrode placement and reconstruction. 1) Images from 3T MRI suffer from spatial 
distortions that may vary from patient to patient and which we did not correct for. 2) 
The hypointense zone in MRI does not tightly correspond to the STN [12, 19]. 3) 
There are mechanical tolerances in the adjustment of the stereotactic frame. 4) We 
do not account for distortions of local tissue in the target area due to the insertion of 
electrodes. 5) The final stimulation electrode is inserted through an empty trajectory 
under visual inspection of x-ray images. This procedure may be affected by brain 
shift due to mechanical strain and/or loss of cerebrospinal fluid. The deviation 
between MR-target and reconstructed site may thus be maximal during the 
perioperative CT and may diminish as cerebrospinal fluid is replenished. 6) The 
typical error in CT-MR image fusion by the StealthMerge algorithm amounts to 1.2 
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mm [15]. 7) Identification of the electrode tip on volumetric CT scans has a spatial 
resolution that is limited by the distance between CT slices. 8) Mirroring all sites on 
the left hemisphere neglects that in most patients the geometry of left and right 
hemisphere is correlated: The difference between hemispheres in one patient (intra-
individual variability) is smaller than the differences between patients (inter-individual 
variability). 
 
Applicability of the mean atlas for target visualization in STN 
The 3D-Morel Atlas uses the mean to represent the distribution of anatomical 
characteristics of the STN in ten brains. Interestingly, the overlap between the 
distribution of stimulation sites and the mean STN amounts to 95% of sites. This 
amounts to a high degree of congruence between the atlas and information derived 
from image analysis of MR and CT, intraoperative electrophysiology, and 
neurological testing. The STN volume in the atlas thus provides a good 
representation of the STN in our patients, even though we have adapted only for 
ventricular width. The accuracy is certainly not sufficient to advocate atlas-based 
“indirect” targeting. But all current approaches to reconstruct stimulation sites show a 
more or less wide distribution [14, 18, 20, 23]. Our finding of the median of the 
optimal stimulation sites in the dorso-lateral STN agrees with reports that stimulation 
in the dorso-lateral STN [5, 22] improves motor symptoms in PD patients.  
 
 
CONCLUSIONS 
 
The cluster of individual stimulation sites – as deduced from preoperative MR, 
intraoperative electrophysiology and neurological testing in PD patients – showed a 
high degree of congruence with the atlas. Even with limited adaptation to the 
individual patient’s brain, the mean 3D Morel Atlas is thus a useful tool for 
postoperative visualization of the stimulation electrode with respect to STN as the 
target. This represents the first clinical evaluation of the recently created atlas. 
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FIGURES 
 
 
 
Figure 1. Projections of the quadripolar electrode onto the atlas. View of 
an implanted electrode from anterior. Optimal stimulation was at the second most 
dorsal contact. Electrode shaft (blue) and stimulation contacts (red). Subthalamic 
Nucleus (STN, transparent green); Red Nucleus (red); Thalamus (gray) with thalamic 
nuclei: Ventral Anterior parvocellular division (VApc), Ventral Lateral anterior division 
(VLa). 
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Figure 2. Sites of optimal stimulation as determined in postoperative 
clinical practice. View on the axial plane. Subthalamic Nucleus (STN, transparent 
green); Red Nucleus (red); Mamillothalamic tract (blue) are clipped at at Zvert =-4mm. 
All structures are mirrored to be depicted on the left hemisphere. Since the location of 
left and right STN are in general highly correlated, the left and right stimulation sites 
in the same patient are not statistically independent. The cube is positioned at the 
site where target planning was initiated (Xlat=±12mm, Yap=-4mm, Zvert=-4mm). Each 
sphere depicts the center of the optimal contact chosen for stimulation in individual 
patients before correction for ventricular width. The spheres are small (diameter = 
0.4mm) for better visibility. The red cylinder is centered on the mean of the 
coordinates of the optimal stimulation site (Xlat=±12.1mm, Yap=-1.7mm, Zvert=-2.8mm) 
and oriented along the mean angles AFAP=56° and AMSP=26°. The dimensions of 
the cylinder correspond to that of a pole of Medtronic Model 3389 electrode (diameter 
1.27mm, height 1.5mm). 
 
 
 
 
